Patent Assignment
Reel/Frame 029732/0858
Assignment of Assignor's Interest
Recorded: 2013-01-31
Pages: 12
Assignor
DEUTERIA PHARMACEUTICALS INC
Executed: 2012-12-03
Assignee
PROTIA, LLC
15025 BROILI DR, RENO, NEVADA, 89511
Covered Properties
(16)
Deuterium-Enriched Oseltamivir
PCT:
PCT/US2008/067425 ↗
Deuterium-Enriched Atorvastatin
Application:
11/745,704 →
Publication:
US 2008/0280970
Deuterium-Enriched Oxybutynin
Deuterium-Enriched Oseltamivir
Deuterium-Enriched Atorvastatin
Deuterium-Enriched Capecitabine
Deuterium-Enriched Nelarabine
Deuterium-Enriched Topotecan
Deuterium-Enriched Risperidone
Deuterium-Enriched Sdx-101
Deuterium-Enriched Oxybutynin
Application:
12/368,651 →
Publication:
US 2009/0156671
Deuterium-Enriched Nelarabine
Application:
60/972,229 →
Deuterium-Enriched Topotecan
Application:
60/972,250 →
Deuterium-Enriched Capecitabine
Application:
60/972,764 →
Deuterium-Enriched Risperidone
Application:
60/972,789 →
Deuterium-Enriched Sdx-101
Application:
60/975,154 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.